# Casdin Capital's Biotech Investments: 53 Startups in Its Portfolio (2026) > The 53 Biotech startups Casdin Capital has backed, by stage: $8.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/casdin-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 21 - [Editas Medicine](https://millionrounds.com/company/editas-medicine) - [Fulcrum Therapeutics](https://millionrounds.com/company/fulcrum-therapeutics) - [*CT* City Therapeutics](https://millionrounds.com/company/city-therapeutics) - [Voyager Therapeutics](https://millionrounds.com/company/voyager-therapeutics) - [*BB* Bolt Biotherapeutics](https://millionrounds.com/company/bolt-biotherapeutics) - [Generation Bio](https://millionrounds.com/company/generation-bio) - [Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics) - [Tenaya Therapeutics](https://millionrounds.com/company/tenaya-therapeutics) - [MOMA Therapeutics](https://millionrounds.com/company/moma-therapeutics) - [*I* Idrx](https://millionrounds.com/company/idrx) - [Variant Bio](https://millionrounds.com/company/variant-bio) - [*M* MyoKardia](https://millionrounds.com/company/myokardia) - [*CT* Celsius Therapeutics](https://millionrounds.com/company/celsius-therapeutics) - [Cedilla Therapeutics](https://millionrounds.com/company/cedilla-therapeutics) - [Exo Therapeutics](https://millionrounds.com/company/exo-therapeutics) - [Hexagon Bio](https://millionrounds.com/company/hexagon-bio) - [*O* ONI](https://millionrounds.com/company/oni) - [Zentera Therapeutics](https://millionrounds.com/company/zentera-therapeutics) - [*MT* Magenta Therpeutics](https://millionrounds.com/company/magenta-therpeutics) - [Vineti](https://millionrounds.com/company/vineti) - [Omicia](https://millionrounds.com/company/omicia) ## Stage not reported 11 - [4D Molecular Therapeutics](https://millionrounds.com/company/4d-molecular-therapeutics) - [Leyden Labs](https://millionrounds.com/company/leyden-labs) - [Vanqua Bio](https://millionrounds.com/company/vanqua-bio) - [Contineum Therapeutics](https://millionrounds.com/company/contineum-therapeutics) - [Remix Therapeutics](https://millionrounds.com/company/remix-therapeutics) - [Gritstone bio](https://millionrounds.com/company/gritstone-bio) - [Notch Therapeutics](https://millionrounds.com/company/notch-therapeutics) - [Xcell Biosciences](https://millionrounds.com/company/xcell-biosciences) - [Sexton Biotechnologies](https://millionrounds.com/company/sexton-biotechnologies) - [Prime Medicine](https://millionrounds.com/company/prime-medicine) - [Amplo Biotechnology](https://millionrounds.com/company/amplo-biotechnology) ## Series C and later 11 - [Blueprint Medicines](https://millionrounds.com/company/blueprint-medicines) - [Relay Therapeutics](https://millionrounds.com/company/relay-therapeutics) - [23andMe](https://millionrounds.com/company/23andme) - [Magenta Therapeutics](https://millionrounds.com/company/magenta-therapeutics) - [908 Devices](https://millionrounds.com/company/908-devices) - [Genome Medical](https://millionrounds.com/company/genome-medical) - [Cerevance](https://millionrounds.com/company/cerevance) - [*BD* Black Diamon Therapeutics](https://millionrounds.com/company/black-diamon-therapeutics) - [*C* Codiak](https://millionrounds.com/company/codiak) - [PACT Pharma](https://millionrounds.com/company/pact-pharma) - [TMRW Life Sciences](https://millionrounds.com/company/tmrw-life-sciences) ## Series A 10 - [Codiak Biosciences](https://millionrounds.com/company/codiak-biosciences) - [Mnemo Therapeutics](https://millionrounds.com/company/mnemo-therapeutics) - [Faze Medicines](https://millionrounds.com/company/faze-medicines) - [Exai Bio](https://millionrounds.com/company/exai-bio) - [Celsius](https://millionrounds.com/company/celsius) - [A2 Biotherapeutics](https://millionrounds.com/company/a2-biotherapeutics) - [Depixus](https://millionrounds.com/company/depixus) - [Apton Biosystems](https://millionrounds.com/company/apton-biosystems) - [Molecular Assemblies](https://millionrounds.com/company/molecular-assemblies) - [InnoSIGN](https://millionrounds.com/company/innosign) ## Segment by segment ### Series B 21 startups · $2.8B raised - [**Editas Medicine**](https://millionrounds.com/company/editas-medicine) Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases. United States $335M - [**Fulcrum Therapeutics**](https://millionrounds.com/company/fulcrum-therapeutics) Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause. United States $310M - [*CT* **City Therapeutics**](https://millionrounds.com/company/city-therapeutics) United States $235M - [**Voyager Therapeutics**](https://millionrounds.com/company/voyager-therapeutics) Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology. United States $205M - [*BB* **Bolt Biotherapeutics**](https://millionrounds.com/company/bolt-biotherapeutics) Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy. United States $189M - [**Generation Bio**](https://millionrounds.com/company/generation-bio) Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders. United States $176M - [**Neon Therapeutics**](https://millionrounds.com/company/neon-therapeutics) NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer. United States $161M - [**Tenaya Therapeutics**](https://millionrounds.com/company/tenaya-therapeutics) Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease. United States $152M ### Stage not reported 11 startups · $891M raised - [**4D Molecular Therapeutics**](https://millionrounds.com/company/4d-molecular-therapeutics) 4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions. United States $307M - [**Leyden Labs**](https://millionrounds.com/company/leyden-labs) Leyden Labs, founded in June 2020 in Leiden, Netherlands, is a biotechnology company focused on developing innovative solutions fo Netherlands $221M - [**Vanqua Bio**](https://millionrounds.com/company/vanqua-bio) Vanqua Bio is a biopharmaceutical company based in Chicago, founded in 2019. United States $130M - [**Contineum Therapeutics**](https://millionrounds.com/company/contineum-therapeutics) Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases. United States $99M - [**Remix Therapeutics**](https://millionrounds.com/company/remix-therapeutics) Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines. United States $60M - [**Gritstone bio**](https://millionrounds.com/company/gritstone-bio) Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases. United States $33M - [**Notch Therapeutics**](https://millionrounds.com/company/notch-therapeutics) Notch Therapeutics is an early-stage biotechnology company based in Vancouver, Canada, focused on immune cell therapy. Canada $16M - [**Xcell Biosciences**](https://millionrounds.com/company/xcell-biosciences) Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance. United States $14M ### Series C and later 11 startups · $3.9B raised - [**Blueprint Medicines**](https://millionrounds.com/company/blueprint-medicines) Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. United States $1.4B - [**Relay Therapeutics**](https://millionrounds.com/company/relay-therapeutics) Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion. United States $932M - [**23andMe**](https://millionrounds.com/company/23andme) United States $729M - [**Magenta Therapeutics**](https://millionrounds.com/company/magenta-therapeutics) Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. United States $187M - [**908 Devices**](https://millionrounds.com/company/908-devices) 908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry. United States $168M - [**Genome Medical**](https://millionrounds.com/company/genome-medical) Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine. United States $98M - [**Cerevance**](https://millionrounds.com/company/cerevance) Cerevance is a private, clinical-stage biopharmaceutical company based in Boston, Massachusetts, founded in 2016. United States $89M - [*BD* **Black Diamon Therapeutics**](https://millionrounds.com/company/black-diamon-therapeutics) United States $85M ### Series A 10 startups · $544M raised - [**Codiak Biosciences**](https://millionrounds.com/company/codiak-biosciences) Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics. United States $100M - [**Mnemo Therapeutics**](https://millionrounds.com/company/mnemo-therapeutics) Mnemo Therapeutics is a biotechnology company based in Paris, founded in 2019. France $90M - [**Faze Medicines**](https://millionrounds.com/company/faze-medicines) Faze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020. United States $81M - [**Exai Bio**](https://millionrounds.com/company/exai-bio) Exai Bio is a biotechnology company based in Palo Alto, California, founded in 2021. United States $68M - [**Celsius**](https://millionrounds.com/company/celsius) Celsius Network is a decentralized financial services platform founded in 2017, focused on bridging traditional finance and blockc United States $65M - [**A2 Biotherapeutics**](https://millionrounds.com/company/a2-biotherapeutics) A2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses. United States $57M - [**Depixus**](https://millionrounds.com/company/depixus) Depixus is a life-science technology company based in Paris, France, specializing in magnetic force spectroscopy (MFS) to analyze France $35M - [**Apton Biosystems**](https://millionrounds.com/company/apton-biosystems) Apton Biosystems develops an optical system designed for sequencing and protein detection. - $25M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Casdin Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Casdin Capital portfolio map** 71 startups · $11B](https://millionrounds.com/portfolio-maps/casdin-capital-portfolio-map)[Co-investors **Who invests with Casdin Capital** 59 co-investors](https://millionrounds.com/portfolio-maps/casdin-capital-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio) ## Raising from investors like Casdin Capital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)